Wednesday, January 19, 2022

Given no current update, GBS Inc. (GBS) stock shines during pre-market

GBS Inc. (NASDAQ: GBS) stock declined by 23.17% at last close however the GBS stock price moves up during pre-market by 15.08%. GBS Inc. is a life sciences firm that creates non-invasive, real-time screening and medical tests for individuals and their primary care physicians.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


GBS stock’ Recent Development

GBS Inc. has announced that in partnership with Life Science Biosensor Diagnostics Pty Ltd (LSBD), the licensor of the Rapid Saliva Glucose Test, LSBD has submitted a request for Breakthrough Device Designation with the U.S. Food and Drug Administration (FDA).


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


The goal of the FDA Devices Breakthrough Program application is to give LSBD a faster road to regulatory clearance for their non-invasive, real-time Saliva Glucose test.

For the Asia Pacific (APAC) Region, GBS is the license holder of LSBD’s Biosensor Platform. GBS also has 50% of BiosensX (North America) Inc., which is the North American Region’s licensee. The Rapid Saliva Glucose Assays are part of the Biosensor Platform, which also comprises a suite of 150 distinct diagnostic point-of-care tests. The Biosensor is a tiny organic thin-film transistor diagnostic test that was created at Newcastle University with the goal of allowing reliable salivary glucose monitoring in real-time at the moment.

Dr. Steven Boyages, the Interim GBS CEO and Chairman of the Board commented that,

They think that this technology will cover a significant and critical gap in examining the effectiveness of the millions of diabetics worldwide. This disparity is especially visible in the middle of the COVID-19 epidemic since poor diabetes control worsens morbidity and death from infection.

Furthermore,

The FDA’s Breakthrough Devices Program provides for the accelerated approval of medical equipment and goods that enable more appropriate cures or diagnoses for life-threatening or permanently disabling illnesses or disorders, such as diabetes. The Program’s goal is to give patients and health care professionals early access to innovative medical devices by accelerating their development, assessment, and review.

Latest news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

Related news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

1745

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam